Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5637-5644

  Xie, Yuan Jie ^a   Long, Zhi Feng ^a   He, Xiu Sheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Carcinogenesis; EBV encoded BART miRNAs; miRNAs; Nasopharyngeal carcinoma

Indexed keywords

CARRIER PROTEIN; MICRORNA;

ANIMAL; EPSTEIN BARR VIRUS; GENETICS; HUMAN; NASOPHARYNX TUMOR;

ANIMALS; CARRIER PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS;

EID: 84890518355     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5637     Document Type: Short Survey

References (83)

1. Akao Y, Nakagawa Y, Naoe T (2006). let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull, 29, 903-6.
2. Alajez NM, Lenarduzzi M, Ito E, et al (2011). MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res, 71, 2381-91.
3. Alajez NM, Shi W, Hui AB, et al (2010). Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis, 1, e85.
4. Barth S, Meister G, Grasser FA (2011). EBV-encoded miRNAs. Biochim Biophys Acta, 1809, 631-40.
5. Cai X, Schafer A, Lu S, et al (2006). Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog, 2, e23.
6. Cameron JE, Yin Q, Fewell C, et al (2008). Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol, 82, 1946-58.
7. Cao JY, Mansouri S, Frappier L (2012). Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J Virol, 86, 382-94.
8. Cao SM, Simons MJ, Qian CN (2011). The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer, 30, 114-9.
9. Chan JY, Gao W, Ho WK, Wei WI, Wong TS (2012). Overexpression of Epstein-Barr virus-encoded microRNABART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res, 32, 3201-10.
10. Chen HC, Chen GH, Chen YH, et al (2009). MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 100, 1002-11.
11. Chen L, Tang Y, Wang J, Yan Z, Xu R (2013). miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. Biochem Biophys Res Commun, 435, 745-50.
12. Chen SJ, Chen GH, Chen YH, et al (2010). Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One, 5, doi:pii: e12745. 10.1371/journal.pone.0012745.
13. Cho WC (2007). Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer, 6, doi: 10.1186/1476-4598-6-1
14. Choy EY, Siu KL, Kok KH, et al (2008). An Epstein-Barr virusencoded microRNA targets PUMA to promote host cell survival. J Exp Med, 205, 2551-60.
15. Cosmopoulos K, Pegtel M, Hawkins J, et al (2009). Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol, 83, 2357-67.
16. Dawson CW, Port RJ, Young LS (2012). The role of the EBVencoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol, 22, 144-53.
17. Deng M, Tang H, Zhou Y, et al (2011). miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci, 124, 2997-3005.
18. Deng M, Ye Q, Qin Z, et al (2013). miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol, 34, 1793-800.
19. Dolken L, Malterer G, Erhard F, et al (2010). Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe, 7, 324-34.
20. Du ZM, Hu LF, Wang HY, et al (2011). Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One, 6, e19137.
21. Edwards RH, Marquitz AR, Raab-Traub N (2008). Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol, 82, 9094-106.
22. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013). MicroRNAs in human cancer. Adv Exp Med Biol, 774, 1-20.
23. Garzon R, Marcucci G, Croce CM (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov, 9, 775-89.
24. Guo X, Liao Q, Chen P, et al (2012). The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol, 138, 49-56.
25. He ML, Luo MX, Lin MC, Kung HF (2012). MicroRNAs: potential diagnostic markers and therapeutic targets for EBVassociated nasopharyngeal carcinoma. Biochim Biophys Acta, 1825, 1-10.
26. Hennessey PT, Sanford T, Choudhary A, et al (2012). Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One, 7, e32307.
27. Hui AB, Bruce JP, Alajez NM, et al (2011). Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res, 17, 7539-50.
28. Jr Meckes DG, Shair KH, Marquitz AR, et al (2010). Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A, 107, 20370-5.
29. Kim DN, Chae HS, Oh ST, et al (2007). Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol, 81, 1033-6.
30. Kim DN, Lee SK (2012). Biogenesis of Epstein-Barr virus microRNAs. Mol Cell Biochem, 365, 203-10.
31. Kok KH, Lei T, Jin DY (2010). Identification and validation of the cellular targets of virus-encoded microRNAs. Methods Mol Biol, 667, 319-26.
32. Li G, Liu Y, Su Z, et al (2013). MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer, doi: 10.1016/j. ejca.2013.03.001.
33. Li G, Wu Z, Peng Y, Liu X, et al (2010). MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett, 299, 29-36.
34. Li JX, Lu TX, Huang Y, Han F (2012). Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. Sci World J, doi: 10.1100/2012/719754
35. Li T, Chen JX, Fu XP, et al (2011). microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep, 25, 1353-63.
36. LIANG BJ, LI XP, LU J, et al (2012). [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 47, 298-304.
37. Liu N, Chen NY, Cui RX, et al (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol, 13, 633-41.
38. Liu X, Lv XB, Wang XP, et al (2012). MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle, 11, 2495-506.
39. Lo AK, Dawson CW, Jin DY, Lo KW (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol, 227, 392-403.
40. Lo AK, To KF, Lo KW, et al (2007). Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A, 104,16164-9.
41. Lu J, He ML, Wang L, et al (2011). MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res, 71, 225-33.
42. Lung RW, Wang X, Tong JH, et al (2012). A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma. Mol Carcinog, doi: 10.1002/mc.21937.
43. Luo Z, Dai Y, Zhang L, et al (2013). miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis, 34, 415-25.
44. Luo Z, Zhang L, Li Z, et al (2012). An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics, doi: 10.1186/1755-8794-5-3.
45. Marquitz AR, Mathur A, Nam CS, Raab-Traub N (2011). The Epstein-Barr Virus BART microRNAs target the proapoptotic protein Bim. Virology, 412, 392-400.
46. Marquitz AR, Raab-Traub N (2012). The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol, 22,166-72.
47. Mei J, Bachoo R, Zhang CL (2011). MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol, 31,3584-92.
48. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009). Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe, 5, 376-85.
49. Ng WT, Lee MC, Hung WM, et al (2011). Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 79, 420-8.
50. Oh SY, Ju Y, Park H (2009). A highly effective and longlasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol Cells, 28,341-5.
51. Ohshima K, Inoue K, Fujiwara A, et al (2010). Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One, 5, e13247.
52. Paik JH, Jang JY, Jeon YK, et al (2011). MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res, 17, 4761-71.
53. Pan J, Hu H, Zhou Z, et al (2010). Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep, 24, 105-12.
54. Polesel J, Serraino D, Negri E, et al (2013). Consumption of fruit, vegetables, and other food groups and the risk of nasopharyngeal carcinoma. Cancer Causes Control, 24, 1157-65.
55. Qu C, Liang Z, Huang J, et al (2012). MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle, 11, 785-96.
56. Qu H, Xu W, Huang Y, Yang S (2011). Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev, 12, 1117-25.
57. Sengupta S, den Boon JA, Chen IH, et al (2008). MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, upregulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A, 105, 5874-8.
58. Shair KH, Schnegg CI, Raab-Traub N (2008). EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res, 68, 6997-7005.
59. Twu CW, Wang WY, Liang WM, et al (2007). Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 67, 130-7.
60. Wang W, Le W, Cho DY, Hwang PH, Upadhyay D (2011). Novel effects of statins in enhancing efficacy of chemotherapy in vitro in nasopharyngeal carcinoma. Int Forum Allergy Rhinol, 1, 284-9.
61. Webb N, Connolly G, Tellam J, Yap AS, Khanna R (2008). Epstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1. PLoS One, 3, e3254.
62. Wijnhoven BP, Hussey DJ, Watson DI, et al (2010). MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg, 97, 853-61.
63. Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY (2012). Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer, 118, 698-710.
64. Wong TS, Man OY, Tsang CM, et al (2011). MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol, 137, 415-22.
65. Wu CD, Kuo YS, Wu HC, Lin CT (2011). MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci, doi: 10.1186/1423-0127-18-80.
66. Wu H, Mo YY (2009). Targeting miR-205 in breast cancer. Expert Opin Ther Targets, 13, 1439-48.
67. Xia H, Cheung WK, Sze J, et al (2010). miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem, 285, 36995-7004.
68. Xia H, Ng SS, Jiang S, et al (2010). miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun, 391, 535-41.
69. Xia XM, Jin WY, Shi RZ, Zhang YF, Chen J (2010). Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer. Oncol Lett, 1, 1045-1047.
70. Xu X, Yang H, Huo X (2004). [Expression and significance of PTEN in nasopharyngeal carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi, 18, 658-9.
71. Yi C, Wang Q, Wang L, et al (2012). MiR-663, a microRNA targeting p21 (WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene, 31, 4421-33.
72. Yoshizaki T, Ito M, Murono S, et al (2012). Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx, 39, 137-44.
73. You S, Zhang F, Meng F, et al (2011). EBV-encoded LMP1 increases nuclear beta-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma. Tumour Biol, 32, 623-30.
74. Yu H, Lu J, Zuo L, et al (2012). Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells. J Virol, 86, 3088-99.
75. Yu L, Lu J, Zhang B, et al (2013). miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett, 5, 1223-8.
76. Yu X, Zhen Y, Yang H, et al (2013). Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis, 4, e634.
77. Zeng X, Xiang J, Wu M, et al (2012). Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One, 7, e46367.
78. Zhang JX, Qian D, Wang FW, et al (2013). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Lett, 329, 91-8.
79. Zhang L, Deng T, Li X, et al (2010). microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis, 31, 559-66.
80. Zhang LY, Ho-Fun LV, Wong AM, et al (2013). MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis, 34, 454-63.
81. Zhong W, He B, Quan T, et al (2013). [Expression of miR-143 in nasopharyngeal carcinoma cell lines and its effect on cell adhesion ability]. Nan Fang Yi Ke Da Xue Xue Bao, 33, 582-5.
82. Zhou Y, Zheng J, Deng J, et al (2013). A sequence polymorphism in miRNA-608 predicts recurrence after radiotherapy of nasopharyngeal carcinoma. Cancer Res, 73, 5151-62.
83. Zhu JY, Pfuhl T, Motsch N, et al (2009). Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol, 83, 3333-41.